Clinical trials
Terminated Phase 3 trials in Georgia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 5 |
| 2020 | 6 |
| 2021 | 14 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 3 |
| Anthera Pharmaceuticals | 2 |
| Areteia Therapeutics | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Immunovant Sciences GmbH | 2 |
| UCB Biopharma SRL | 2 |
| argenx | 2 |
| Alvotech Swiss AG | 1 |
| ApcinteX Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 6 |
| Crohn Disease | 4 |
| Renal Insufficiency, Chronic | 3 |
| Asthma | 2 |
| Autoimmune Diseases | 2 |
| COVID-19 | 2 |
| Colitis, Ulcerative | 2 |
| Graves Ophthalmopathy | 2 |
| Hypertension | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.